Acquisition Announced

Jazz Pharmaceuticals acquisition of Actio Biosciences

US$820m consideration

Announced 10 Aug 2026

Advisers

Actio Biosciences

Target

Financial adviser
Legal adviser

Jazz Pharmaceuticals

Acquirer

Financial adviser
Legal adviser
Target
Actio Biosciences
Acquirer
Jazz Pharmaceuticals
Target based in
United States
Buyer based in
Ireland
Sector
Biotech
Tags
Biotech, Drug Development, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.